Provided by Tiger Trade Technology Pte. Ltd.

vTv Therapeutics

30.19
-0.8200-2.64%
Volume:38.69K
Turnover:1.18M
Market Cap:118.89M
PE:-28.59
High:31.03
Open:31.03
Low:29.80
Close:31.01
52wk High:44.00
52wk Low:19.50
Shares:3.94M
Float Shares:2.42M
Volume Ratio:1.61
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0558
EPS(LYR):-3.2022
ROE:-15.80%
ROA:-10.14%
PB:5.58
PE(LYR):-9.43

Loading ...

vTv Therapeutics Q2 EPS $(1.05) Misses $(0.99) Estimate

Benzinga Earnings
·
Aug 06

vTv Therapeutics Q2 FY26 Net Loss Widens to $13.1 Million; R&D Expenses More than Doubled to $8.8 Million

Reuters
·
Aug 06

vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Aug 06

VTv Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Reuters
·
Jul 29

vTv Therapeutics Grants 23,500 Inducement Stock Options at Weighted Average Exercise Price of $31.95 Per Share

Reuters
·
Jul 29

vTv Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 29

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 29

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Urogen Pharma (URGN) and vTv Therapeutics (VTVT)

TIPRANKS
·
Jul 16

Vtv Therapeutics Inc : Btig Raises Target Price to $57 from $49

THOMSON REUTERS
·
Jul 16

Vtv Therapeutics Grants 12,500 Inducement Stock Options at Weighted Average Exercise Price of $34.15

Reuters
·
Jul 03

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 03

vTv Therapeutics Shareholders Approve Directors, Question Executive Pay

TIPRANKS
·
Jun 30

Vtv Therapeutics Holds Annual Shareholder Meeting

Reuters
·
Jun 30

vTv Therapeutics grants 2,500 inducement stock options at $34.3 per share

Reuters
·
Jun 03

vTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 03

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 03

H.C. Wainwright Sticks to Their Buy Rating for vTv Therapeutics (VTVT)

TIPRANKS
·
May 27

vTv Therapeutics: Buy Rating Reiterated on Favorable Risk-Reward and Clinical Momentum; $67 Price Target Unchanged

TIPRANKS
·
May 15

Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (VTVT), Waters (WAT) and Alpha Teknova (TKNO)

TIPRANKS
·
May 14

Analyst Maintains Buy on vTv Therapeutics, Reiterates Unchanged $49 Price Target Amid Progress of Cadisegliatin Program

TIPRANKS
·
May 14